Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 30

1.

Development of a Pediatric Adverse Events Terminology.

Gipson DS, Kirkendall ES, Gumbs-Petty B, Quinn T, Steen A, Hicks A, McMahon A, Nicholas S, Zhao-Wong A, Taylor-Zapata P, Turner M, Herreshoff E, Jones C, Davis JM, Haber M, Hirschfeld S.

Pediatrics. 2017 Jan;139(1). pii: e20160985. doi: 10.1542/peds.2016-0985.

2.

Population Pharmacokinetics and Exploratory Pharmacodynamics of Lorazepam in Pediatric Status Epilepticus.

Gonzalez D, Chamberlain JM, Guptill JT, Cohen-Wolkowiez M, Harper B, Zhao J, Capparelli EV; Best Pharmaceuticals for Children Act – Pediatric Trials Network Steering Committee.

Clin Pharmacokinet. 2017 Aug;56(8):941-951. doi: 10.1007/s40262-016-0486-0.

PMID:
27943220
3.

Fluconazole Prophylaxis for the Prevention of Candidiasis in Premature Infants: A Meta-analysis Using Patient-level Data.

Ericson JE, Kaufman DA, Kicklighter SD, Bhatia J, Testoni D, Gao J, Smith PB, Prather KO, Benjamin DK Jr; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committeea; Fluconazole Prophylaxis Study Team on behalf of the Best Pharmaceuticals for Children Act–Pediatric Trials Network Steering Committee.

Clin Infect Dis. 2016 Sep 1;63(5):604-10. doi: 10.1093/cid/ciw363. Epub 2016 Jun 13.

4.

Sildenafil and retinopathy of prematurity risk in very low birth weight infants.

Samiee-Zafarghandy S, van den Anker JN, Laughon MM, Clark RH, Smith PB, Hornik CP; Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee.

J Perinatol. 2016 Feb;36(2):137-40. doi: 10.1038/jp.2015.126. Epub 2015 Oct 22.

5.

Lithium in the Acute Treatment of Bipolar I Disorder: A Double-Blind, Placebo-Controlled Study.

Findling RL, Robb A, McNamara NK, Pavuluri MN, Kafantaris V, Scheffer R, Frazier JA, Rynn M, DelBello M, Kowatch RA, Rowles BM, Lingler J, Martz K, Anand R, Clemons TE, Taylor-Zapata P.

Pediatrics. 2015 Nov;136(5):885-94. doi: 10.1542/peds.2015-0743. Epub 2015 Oct 12.

6.

Cefepime and Ceftazidime Safety in Hospitalized Infants.

Arnold CJ, Ericson J, Cho N, Tian J, Wilson S, Chu VH, Hornik CP, Clark RH, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee.

Pediatr Infect Dis J. 2015 Sep;34(9):964-8. doi: 10.1097/INF.0000000000000778.

7.

Gaps in Drug Dosing for Obese Children: A Systematic Review of Commonly Prescribed Emergency Care Medications.

Rowe S, Siegel D, Benjamin DK Jr; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee.

Clin Ther. 2015 Sep 1;37(9):1924-32. doi: 10.1016/j.clinthera.2015.08.006. Epub 2015 Aug 29. Review.

8.

Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia.

Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.

J Clin Pharmacol. 2016 Mar;56(3):298-306. doi: 10.1002/jcph.598. Epub 2015 Oct 15.

9.

Simultaneous determination of trimethoprim and sulfamethoxazole in dried plasma and urine spots.

Gonzalez D, Melloni C, Poindexter BB, Yogev R, Atz AM, Sullivan JE, Mendley SR, Delmore P, Delinsky A, Zimmerman K, Lewandowski A, Harper B, Lewis KC, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act--Pediatric Trials Network Administrative Core Committee.

Bioanalysis. 2015;7(9):1137-49. doi: 10.4155/bio.15.38.

10.

Safety of octreotide in hospitalized infants.

Testoni D, Hornik CP, Neely ML, Yang Q, McMahon AW, Clark RH, Smith PB; Best Pharmaceuticals for Children Act — Pediatric Trials Network Administrative Core Committee.

Early Hum Dev. 2015 Jul;91(7):387-92. doi: 10.1016/j.earlhumdev.2015.04.008. Epub 2015 May 15.

11.

Pharmacokinetics, Pharmacodynamics, and Safety of Lisinopril in Pediatric Kidney Transplant Patients: Implications for Starting Dose Selection.

Trachtman H, Frymoyer A, Lewandowski A, Greenbaum LA, Feig DI, Gipson DS, Warady BA, Goebel JW, Schwartz GJ, Lewis K, Anand R, Patel UD; Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee.

Clin Pharmacol Ther. 2015 Jul;98(1):25-33. doi: 10.1002/cpt.127. Epub 2015 May 2.

12.

Use and Safety of Erythromycin and Metoclopramide in Hospitalized Infants.

Ericson JE, Arnold C, Cheeseman J, Cho J, Kaneko S, Wilson E, Clark RH, Benjamin DK Jr, Chu V, Smith PB, Hornik CP; Best Pharmaceuticals for Children Act–Pediatric Trials Network Administrative Core Committee.

J Pediatr Gastroenterol Nutr. 2015 Sep;61(3):334-9. doi: 10.1097/MPG.0000000000000792.

13.

Anaerobic antimicrobial therapy after necrotizing enterocolitis in VLBW infants.

Autmizguine J, Hornik CP, Benjamin DK Jr, Laughon MM, Clark RH, Cotten CM, Cohen-Wolkowiez M, Benjamin DK, Smith PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee.

Pediatrics. 2015 Jan;135(1):e117-25. doi: 10.1542/peds.2014-2141. Epub 2014 Dec 15.

14.

Safety of milrinone use in neonatal intensive care units.

Samiee-Zafarghandy S, Raman SR, van den Anker JN, McHutchison K, Hornik CP, Clark RH, Brian Smith P; Best Pharmaceuticals for Children Act—Pediatric Trials Network Administrative Core Committee.

Early Hum Dev. 2015 Jan;91(1):31-5. doi: 10.1016/j.earlhumdev.2014.10.007. Epub 2014 Nov 26.

15.

Use of opportunistic clinical data and a population pharmacokinetic model to support dosing of clindamycin for premature infants to adolescents.

Gonzalez D, Melloni C, Yogev R, Poindexter BB, Mendley SR, Delmore P, Sullivan JE, Autmizguine J, Lewandowski A, Harper B, Watt KM, Lewis KC, Capparelli EV, Benjamin DK Jr, Cohen-Wolkowiez M; Best Pharmaceuticals for Children Act – Pediatric Trials Network Administrative Core Committee.

Clin Pharmacol Ther. 2014 Oct;96(4):429-37. doi: 10.1038/clpt.2014.134. Epub 2014 Jun 20.

16.

Characterization of the population pharmacokinetics of ampicillin in neonates using an opportunistic study design.

Tremoulet A, Le J, Poindexter B, Sullivan JE, Laughon M, Delmore P, Salgado A, Ian-U Chong S, Melloni C, Gao J, Benjamin DK Jr, Capparelli EV, Cohen-Wolkowiez M; Administrative Core Committee of the Best Pharmaceuticals for Children Act-Pediatric Trials Network.

Antimicrob Agents Chemother. 2014 Jun;58(6):3013-20. doi: 10.1128/AAC.02374-13. Epub 2014 Mar 10.

17.

Medication use in the neonatal intensive care unit.

Hsieh EM, Hornik CP, Clark RH, Laughon MM, Benjamin DK Jr, Smith PB; Best Pharmaceuticals for Children Act—Pediatric Trials Network.

Am J Perinatol. 2014 Oct;31(9):811-21. doi: 10.1055/s-0033-1361933. Epub 2013 Dec 17.

18.

Population pharmacokinetics of intravenous acyclovir in preterm and term infants.

Sampson MR, Bloom BT, Lenfestey RW, Harper B, Kashuba AD, Anand R, Benjamin DK Jr, Capparelli E, Cohen-Wolkowiez M, Smith PB; Best Pharmaceuticals for Children Act–Pediatric Trials Network.

Pediatr Infect Dis J. 2014 Jan;33(1):42-9. doi: 10.1097/01.inf.0000435509.75114.3d.

19.

Comparative effectiveness of surfactant preparations in premature infants.

Trembath A, Hornik CP, Clark R, Smith PB, Daniels J, Laughon M; Best Pharmaceuticals for Children Act—Pediatric Trials Network.

J Pediatr. 2013 Oct;163(4):955-60.e1. doi: 10.1016/j.jpeds.2013.04.053. Epub 2013 Jun 12.

20.

Evaluation of the Mercy TAPE: performance against the standard for pediatric weight estimation.

Abdel-Rahman SM, Paul IM, James LP, Lewandowski A; Best Pharmaceuticals for Children Act-Pediatric Trials Network.

Ann Emerg Med. 2013 Oct;62(4):332-339.e6. doi: 10.1016/j.annemergmed.2013.02.021. Epub 2013 Apr 17.

Supplemental Content

Loading ...
Support Center